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Aim: To determine the opinion of health care professionals within Australia, regarding 
acceptable levels of exertion and symptoms, and referral for exercise rehabilitation in patients 
with pulmonary arterial hypertension (PAH).
Method: In 2010, 76 health care professionals at a specialist pulmonary hypertension meet-
ing in Australia were surveyed using a self-administered questionnaire. The questionnaire 
included case studies of patients with PAH in World Health Organization (WHO) functional 
classes II–IV . For each case study, respondents were asked to report their opinion regarding 
the acceptable level of exertion and symptoms during daily activities, and whether they would 
refer the patient for exercise rehabilitation. Three additional questions asked about advice in 
relation to four specific physical activities.
Results: The response rate was 70% (n = 53). Overall, 58% of respondents recommended 
patients undertake daily activities ‘as tolerated’. There was no consensus regarding acceptable 
levels of breathlessness or fatigue, but the majority of respondents considered patients should 
have no chest pain (73%) and no more than mild light-headedness (92%) during daily activities. 
Overall, 63% of respondents would have referred patients for exercise rehabilitation. There was 
little difference in opinion regarding the acceptable level of exertion or symptoms, or referral 
for exercise rehabilitation, according to functional class. However, the patients’ functional class 
did influence the advice given regarding the specific physical activities.
Conclusion: In 2010, there were inconsistencies between individual health care professionals 
within Australia regarding appropriate levels of physical exertion and acceptable symptoms dur-
ing daily activities. Almost two-thirds of the respondents reported they would refer patients for 
exercise rehabilitation.
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Introduction
Pulmonary arterial hypertension (PAH) is characterized by poor exercise toler-
ance and impaired functional capacity. In patients with left heart failure (LHF) 
and chronic obstructive pulmonary disease, similar impairments respond well to 
exercise rehabilitation.1–3 Until recently, however, exercise rehabilitation was dis-
couraged for patients with PAH due to a perceived high risk of adverse outcomes 
associated with physical exertion.4 Historically, symptoms were used to guide 
physical activity and patients were advised to avoid exertion associated with light-
headedness, chest pain, or severe dyspnea.5 Otherwise, little consideration was given Journal of Multidisciplinary Healthcare 2011:4 submit your manuscript | www.dovepress.com
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regarding recommendations for physical activity or exercise 
rehabilitation for individuals with PAH.
The recent introduction of PAH specific therapy has 
led to improved central hemodynamics and prognosis for 
patients with PAH.6 Despite therapy, however, many patients 
with PAH continue to experience significant impairment 
in physical function and quality of life.7 The benefits seen 
following exercise rehabilitation in patients with LHF and 
chronic obstructive pulmonary disease have been achieved 
in the absence of adverse events or clinical deterioration 
and exercise rehabilitation now constitutes an important 
adjunct to medical therapy in these populations.8,9 These 
findings have stimulated an interest in the effects of exercise 
rehabilitation in patients with PAH, but, prior to a feasibility 
study published in Japanese in 2005,10 there were no reports 
of exercise rehabilitation in this population. Between 2006 
and June 2010, a further three studies, with a total of 
51 subjects with PAH who had undergone rehabilitation, 
were published.11–13 Improvements in exercise capacity 
and quality of life were observed following rehabilitation, 
without any adverse events or clinical deterioration.10–13 Since 
June 2010, two further studies of exercise rehabilitation in 
subjects with PAH (with a total of 27 subjects) have been 
published.14,15
It is possible the paucity of data regarding the impact 
of physical activity and exercise on outcomes in PAH has 
made it difficult for clinicians to provide consistent advice 
regarding physical activity and to identify which patients 
are suitable for exercise rehabilitation. The aim of this study 
was to determine the consistency of approach by health 
care professionals who manage patients with PAH within 
Australia, regarding appropriate levels of exertion and 
acceptable symptoms during physical activity, and referral 
for exercise rehabilitation.
Methods
The study used a cross sectional design with data collected 
via a self-administered questionnaire. The questionnaire was 
developed by the investigators specifically for this study (see 
Appendix 1). Although responses were anonymous, respon-
dents were asked to indicate the type of institution that they 
worked in, their professional position, and the number of 
new PAH cases seen each year.
Three scenarios reflective of clinical practice were 
  presented as case studies. These case studies described adults 
with PAH, one in each of the WHO functional classes II, 
III and IV . The data presented for each case study included 
the hemodynamic status (ie, pulmonary artery pressure and 
pulmonary vascular resistance index) obtained from right 
heart catheter assessment, right ventricular function measured 
at rest on an echocardiogram, 6-minute walk distance, and 
arterial blood gas data. For each case scenario, participants 
were instructed to respond to the same seven questions 
in accordance with their usual clinical management. The 
first question asked if they would perform any additional 
investigations. The remaining questions were designed to 
obtain data pertaining to the recommendations the respondent 
would provide regarding daily activity, acceptable symptoms 
on exertion, and whether they would refer the patient 
described in the case study for exercise rehabilitation.
Three additional questions, regarding four specific 
physical activities, were asked to determine the advice the 
respondents would give to patients with PAH, in each of 
the functional classes II–IV . These questions asked whether 
patients with PAH would be advised for or against lifting a 
20 kg weight, exercising in a non-hospital gym, regularly 
using stairs and slopes, or adopting a sedentary lifestyle.
Piloting of the questionnaire was performed in a sample 
of seven health care professionals (medical practitioners, 
n = 3; nurses, n = 2; physiotherapists, n = 2) from the 
  pulmonary hypertension clinic at a tertiary hospital (Royal 
Perth Hospital, Perth, Western Australia). These individuals 
were instructed to complete the questionnaire, and provide 
feedback about its ease of use, applicability, and length. No 
recommendations for change arose from this pilot study.
Participants
The survey was conducted at the Pulmonary Hypertension 
Perspectives Meeting (Sydney, Australia; Pfizer Pharma-
ceuticals Australia) in June 2010. Eighty-nine health care 
professionals who worked in pulmonary hypertension 
clinics within Australia attended the meeting. Seventy-six of 
these participants had a role in advising patients with PAH 
regarding physical activity and exercise. The remaining 
participants were pharmacists (n = 12) and a medical student 
(n = 1). Attendance was by invitation and the purpose of the 
meeting was to provide a forum for experts within the field 
of pulmonary hypertension to discuss best practice and future 
directions in the diagnosis and management of PAH.
This study was approved by the Human Research Ethics 
Committee of Curtin University. Participant consent was 
implied by return of the questionnaires.
Data analysis
Data analysis comprised descriptive statistics. Analysis was per-
formed using SPSS software (v 18; SPSS Inc, Chicago, IL).Journal of Multidisciplinary Healthcare 2011:4 submit your manuscript | www.dovepress.com
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Results
Fifty-three completed questionnaires were returned from 
participants who have a role providing advice to patients 
regarding daily activities, or in referring patients for exercise 
rehabilitation. This represents a response rate of 70%. Some 
respondents did not answer all questions and therefore not 
all percentages presented in the results add to 100.
Demographics
Demographic data of the 53 respondents who completed the 
questionnaire are presented in Table 1.
Responses to the questions reflecting usual clinical 
  practice, in relation to the case studies and four specific 
physical activities, are summarized in Table 2. Data 
pertaining to the responses to all of the questions are 
presented in Appendix 1.
responses to questions relating  
to the case studies
instructions for daily activity
The majority of respondents (67%) stated that they would 
have given the patients verbal advice and 33% would have 
given written advice.
Overall, 58% of respondents stated that they would 
advise the patients to undertake daily activities ‘as   tolerated’, 
regardless of functional class (Table 2). The balance of 
respondents moderated their instructions according to 
functional class. For example, 25% advised moderate   activity 
for patients in functional class II, 9% advised moderate 
activity for patients in functional class III, and only 4% 
advised moderate activity for patients in functional class IV 
(Table 2). Some respondents provided details on how their 
patients would have been guided regarding daily activities. 
These respondents reported that they would have: assessed 
the patient’s exercise capacity, referred the patient for 
physiotherapy and/or pulmonary or cardiac rehabilitation, 
advised the patient to use oxygen therapy during activity, or 
advised the patient to undertake symptom-limited exertion 
(Appendix 1).
Acceptable symptoms during daily activities
Overall, the majority (92%) of respondents considered that 
either no light-headedness (53%) or mild light-headedness 
(39%) was acceptable during daily activities. A minor-
ity (7%) considered that moderate light-headedness was 
acceptable. With regard to chest pain, 73% of respondents 
considered that no chest pain was acceptable. A further 20% 
advised that mild chest pain was acceptable. For both light-
headedness and chest pain there was little variation according 
to functional class (Table 2).
In terms of the breathlessness experienced during physical 
activities, overall 20% of respondents considered minimal, 
44% considered moderate and 31% considered breathlessness 
‘as tolerated’ was acceptable during daily activities. 
  However, more respondents considered   moderate rather 
than minimal breathlessness (51% vs 11%, respectively) 
was acceptable for the patient in functional class IV . When 
considering fatigue levels during daily activities, overall 5% 
of respondents   considered that no fatigue was acceptable. 
A further 27% considered minimal fatigue, 40% considered 
moderate fatigue, and 21% considered that fatigue ‘as 
tolerated’ was acceptable. With the exception of the different 
opinion pertaining to acceptable levels of breathlessness 
for patients in functional class IV compared to patients in 
classes II and III, there was little difference in the level of 
symptoms that was considered acceptable across the func-
tional classes (Table 2).
referral for exercise rehabilitation
Overall, 63% of respondents stated they would have 
referred patients for exercise rehabilitation and this did 
not vary depending on the patients’ functional class 
(Table 2).
Responses to questions regarding specific  
physical activities
Respondents’ advice regarding the recommendations for the 
four specific physical activities varied according to functional 
class. Fifty-seven percent of respondents would have advised 
for, and 36% against, patients in functional class II lifting 
a 20 kg weight. The majority of respondents would have 
advised patients in functional class II to use a non-hospital 
gym (70%) and to regularly use stairs and slopes (79%). The 
majority of respondents would also have advised patients in 
functional class II against adopting a sedentary lifestyle (91%). 
Table 1 Demographics of the 53 respondents
Type of institution Tertiary 
secondary 
Private and public 
Other
41 (77) 
8 (15) 
3 (6) 
1 (2)
Profession respiratory physician 
cardiologist 
rheumatologist 
nurse 
exercise physiologist
19 (36) 
8 (15) 
6 (11) 
19 (36) 
1 (2)
Note: Data are number of responses with percentages given in parentheses.Journal of Multidisciplinary Healthcare 2011:4 submit your manuscript | www.dovepress.com
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For patients in functional class III, 83% of respondents would 
have advised against lifting a 20 kg weight and against 
exercise in a non-hospital gym (72%). A similar number of 
respondents recommended that patients in functional class III 
did and did not regularly use stairs and slopes (51% and 
42%, respectively). Eighty-five percent would have advised 
patients in functional class III against a sedentary lifestyle. 
The majority of respondents stated that they would have 
advised patients in functional class IV not to lift a 20 kg 
weight (92%), not to use a non-hospital gym (87%) and 
not to regularly use stairs or slopes (81%). The majority 
of respondents would have advised patients in functional 
class IV to adopt a sedentary lifestyle (75%).
Discussion
The main findings of this survey of health care professionals 
attending a pulmonary hypertension specific meeting in 
2010 were: (1) there was inconsistency between individuals 
regarding the acceptable level of exertion, breathlessness 
and fatigue during daily activities for patients with PAH; 
(2) there was a consensus that, for these patients, chest 
pain and anything more than mild light-headedness was not 
acceptable during daily activities; (3) approximately two-
thirds of respondents stated they would refer patients for 
exercise rehabilitation; (4) the level of acceptable symptoms 
during daily activities and patterns of referral for exercise 
rehabilitation did not vary greatly according to the patients’ 
functional class, but, (5) advice regarding specific physical 
activities varied according to functional class.
The lack of evidence regarding the safety and impact of 
physical exertion on hemodynamics in patients with PAH has 
made it difficult for clinicians to provide recommendations 
regarding physical activity. Until recently, physical activity 
guidelines for patients with PAH were only available from 
sources such as the Pulmonary Hypertension Association5 
and were based upon studies in subjects with LHF. Patients 
Table 2 Questionnaire responses from the 53 participants
Class II Class III Class IV
Method to guide daily activity Verbal 72 62 68
Written 38 25 36
refer on for instruction 17 26 23
refer for exercise rehabilitation Yes 62 60 66
no 38 32 34
recommended level of exertion during daily activities Mild 6 13 23
Moderate 25 9 4
As tolerated 57 57 60
Acceptable breathlessness during daily activities Minimal 23 26 11
Moderate 44 38 51
As tolerated 30 28 34
Acceptable fatigue during daily activities none 6 8 2
Minimal 33 25 28
Moderate 37 34 50
As tolerated 22 25 17
Acceptable light-headedness during daily activities none 57 51 51
Mild 37 38 41
Moderate 4 4 6
To syncope 0 0 0
Acceptable chest pain during daily activities none 78 74 68
Mild 16 13 30
Moderate 2 4 0
As tolerated 4 2 2
Would you advise a patient to lift a 20 kg weight Yes 36 9 0
no 57 83 92
Would you advise exercise in a non-hospital gym Yes 
no
70 
23
21 
72
6 
87
Would you advise regularly using stairs and slopes Yes 
no
79 
13
51 
42
11 
81
Would you advise a sedentary lifestyle Yes 
no
2 
91
8 
85
17 
75
Notes: Data are percentage of responses. some respondents did not answer all questions and therefore not all percentages add to 100. raw data for the responses to all 
questions are given in Appendix 1.Journal of Multidisciplinary Healthcare 2011:4 submit your manuscript | www.dovepress.com
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with PAH were advised to undertake light to moderate 
aerobic exercise and to avoid exercise to the point of light-
headedness, chest pain, or severe dyspnea. Patients with 
severe functional limitation, and those with a history of 
dizziness and/or fainting, were advised against undertaking 
an exercise program.5
The inconsistency in response in our study, regarding 
acceptable symptoms of breathlessness and fatigue during 
physical activity, is likely to reflect uncertainty about the 
significance of these symptoms. In contrast, the consensus 
regarding the avoidance of light-headedness, a symptom 
suggestive of impaired cardiac output,16 and the majority 
view recommending avoidance of chest pain, a symptom 
suggestive of myocardial ischemia,17 is likely to reflect the 
understanding that these symptoms can represent life threat-
ening events. The inconsistencies in opinion regarding the 
appropriate level of exertion and advice for common daily 
activities, such as lifting a 20 kg weight and the regular use 
of stairs and slopes, suggests uncertainty about the impact 
of general physical activity on patient outcome.
Recently, one randomized controlled trial,11 one non-
randomized controlled trial,15 three intervention trials10,12,14 
and one case report on exercise rehabilitation13 have been 
published. The subjects in these studies had idiopathic PAH 
(n = 83), chronic thrombo-embolic pulmonary hyperten-
sion (n = 8), or PAH associated with connective tissue 
disease (n = 10), or congenital heart disease (n = 1). These 
publications reported positive outcomes associated with 
exercise rehabilitation, achieved in the absence of adverse 
events. To the authors’ knowledge, only one published posi-
tion statement on pulmonary rehabilitation9 and no position 
statements or guidelines on cardiac rehabilitation include 
specific guidelines for exercise rehabilitation in PAH. In 
2008, one publication reviewed exercise responses in PAH 
and discussed exercise prescription for this population.4
In the current study, the finding that only two-thirds of 
respondents recommended exercise rehabilitation for patients 
in functional classes II and III suggests that, in 2010, there 
was uncertainty regarding this intervention, despite publica-
tions describing benefits of exercise training for this popula-
tion.10–13 This uncertainty may be related to the low number of 
subjects in the published reports and the publication of only 
one randomized controlled trial of exercise rehabilitation.
The only reported study of exercise rehabilitation that 
included a substantial number of patients in functional class 
IV was published in Japanese.10 However, in our study it 
was notable that the majority of respondents stated that 
they would refer patients in functional class IV for exercise 
rehabilitation, despite the very limited evidence for exercise 
rehabilitation in this subgroup. It is possible this finding 
relates to a perception that exercise rehabilitation for patients 
in functional class IV will improve functional capacity and 
minimize symptoms during activities of daily living. It may 
also relate to the perceived need for patients with severe 
disease to be educated about the risks of overexertion and 
to be supervised during exercise. The advice for patients in 
functional class IV , regarding the specific physical activities 
presented in this study, demonstrated a conservative approach 
towards physical activity that was not supervised by a health 
care professional.
The point prevalence of idiopathic PAH in Australia 
is estimated at 40 per million18 and therefore, based upon 
Australian population statistics,19 the estimated number of 
patients with idiopathic PAH in Australia is approximately 
900. In 2010, medical practitioners in 47 pulmonary hyper-
tension clinics were licensed to prescribe PAH specific 
pharmaceutical therapies.20 The rarity and complex nature 
of PAH, and strict licensing conditions associated with the 
prescription of PAH medications, means a limited number 
of health care professionals are involved in the management 
of patients with PAH. The relatively small number of 
participants in this study reflects the limited number of health 
care professionals, within Australia, who work with patients 
who have PAH.
Limitations
Attendance at the meeting at which the survey was performed 
was by invitation, resulting in likely selection bias. However, 
it also ensured the respondents were directly involved in the 
management of patients with PAH.
It was not possible to identify any overlap between respon-
dents, in terms of the institutions that were represented, due to 
a deliberate decision to maintain the respondents’ anonymity. 
However, the preservation of anonymity is likely to have had 
a positive influence over the response rate and encouraged 
open responses.
Conclusion
In 2010, health care professionals within Australia were 
inconsistent in opinion regarding appropriate levels of 
exertion and acceptable symptoms during daily activities. 
There appeared to be some uncertainty regarding the role 
of exercise rehabilitation in PAH. The findings of this 
study identify a need for further research to support the 
development of guidelines on physical activity and exercise 
rehabilitation for the PAH population in Australia.Journal of Multidisciplinary Healthcare 2011:4 submit your manuscript | www.dovepress.com
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Appendix 1 
Questionnaire used in the study together with the responses 
to each questions.
Note: Data given in the responses are number of responses 
with percentages given in parentheses.
Activity and exercise guidelines  
for patients with pulmonary  
arterial hypertension (PAH)
Background
There is very little in the literature to guide exercise and phys-
ical activity recommendations for patients with PAH. The 
Royal Perth Hospital Advanced Lung Disease/  Pulmonary 
Hypertension Research Group led by Associate   Professor 
Eli Gabbay, in conjunction with the Curtin University School 
of Physiotherapy, is seeking to determine expert opinion on 
exercise and physical activity guidelines for patients with 
PAH. We therefore request that you complete and return the 
following questionnaire.
Participation is purely voluntary but we strongly 
encourage your contribution. There is no individual iden-
tifying information on this questionnaire and therefore 
anonymity will be protected. Information gained from 
this questionnaire may be used in future presentations and 
publications.
Thank you for taking the time to complete this questionnaire.
For each of the following questions please circle your chosen answer.
  Results
Total number of respondents  (n = 53)
Type of institution:  n (%)
a) Tertiary/major hospital  41 (77)
b)  Secondary/regional hospital  8 (15)
c)  Private practice  3 (6)
d)  General practice  0
e)  Other – please specify_____  1 (2)
Position:
a)  Respiratory (thoracic) physician  19 (36)
b)  Cardiologist  8 (15)
c)  Rheumatologist  6 (11)
d)  Nurse specialist  19 (36)
e)  Exercise physiologist  1 (2)
f)  Other – please specify_____________________________________________________________________
Number of new PAH patients seen per year:
a)  0–10  18 (34)
b)  11–50  24 (45)
c)  51–100  4 (8)
d)  101–150  4 (8)
e)  151–200  0
f)  201–300  2 (4)
g)  .300  0
Two case studies are presented. Please circle the answer(s) that best represents your usual response.
Case 1
44-year-old female
WHO functional Class IV
Six-minute walk distance 85 m on room air.
ABGs on room air PaO2 51 mmHg (6.8 kPa), PaCO2 42 mmHg (5.6 kPa)
PAP 92/55, mean PAP 67 mmHg on resting RHC study
PVRI 2291 dyne/s/m2/cm5Journal of Multidisciplinary Healthcare 2011:4 submit your manuscript | www.dovepress.com
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Severely dilated right ventricle with severe global impairment of RV systolic function
No evidence of thromboembolic disease
All usual tertiary hospital-based assessment related to diagnosis and medical management has been performed
In relation to exercise and activity prescription:  Results
1.    What further investigations would you perform?  n (%)
    a)  None  28 (53)
    b)  Exercise right heart catheter  8 (15)
    c)  Exercise echo  5
    d)  Other – please explain_____________________________________________________________________
Results: lung function tests (n = 2), cardiopulmonary exercise test (CPET) (n = 1), CT angiogram (n = 1), overnight oximetry 
(n = 1) 
_________________________________________________________________________________________________
In the absence of these results:
2.    What instructions for daily activities would you give?
    a)  None  0
    b)  Recommend only mild exertion  12 (23)
    c)  Recommend moderate exertion  2 (4)
    d)  Instruct the patient to continue activity as tolerated  32 (60)
    e)  Other – please explain_____________________________________________________________________
Results: Refer to physio/pulmonary rehab (n = 6), oxygen therapy (n = 4), symptom limited exercise (n = 2), overnight 
oximetry (n = 1)
_________________________________________________________________________________________________
For this question, more than one answer may be selected
3.    How would you guide the patient with respect to their daily activities? Would you:
    a)  Give verbal guidelines  36 (68)
    b)  Give written guidelines  19 (36)
    c)  Refer the patient for instruction  12 (23)
    d)  Refer the patient for exercise rehabilitation  35 (66)
    e)  Other – please explain_____________________________________________________________________
For this patient, which of the following symptoms would you consider to be acceptable during daily activities?
4.    Breathlessness 
    a)  Minimal  6 (11)
    b)  No more than moderate  27 (51)
    c) As much as the patient can tolerate  18 (34)
    d)  Other – please explain_____________________________________________________________________
5.    Light-headedness
    a)  None  27 (51)
    b)  Mild  22 (41)
    c)  Moderate  3 (6)
    d) To the point of syncope  0
    e)  Other – please explain_____________________________________________________________________
6.    Fatigue
    a)  None  1 (2)
    b)  Minimal  15 (28)Journal of Multidisciplinary Healthcare 2011:4 submit your manuscript | www.dovepress.com
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    c)  Moderate fatigue  26 (50)
    d) As much as the patient can tolerate  9 (17)
    e)  Other – please explain_____________________________________________________________________
  7.  Chest pain
    a)  None  36 (68)
    b)  Mild  16 (30)
    c)  Moderate  0
    d) As much as the patient can tolerate  1 (2)
    e)  Other – please explain_____________________________________________________________________
Following 6 months on a maximal dose of Epoprostenol this same patient has the following results:
WHO functional class II
6MWD 405 m on room air
Echo: mild RV dysfunction and RV dilatation
Mean PAP 45 mmHg
PVRI 815 dynes/s/m2/cm5
  Results
  8. What further investigations would you perform?  n (%)
    a)  None  36 (68)
    b)  Exercise right heart catheter  5 (9)
    c)  Exercise echo  3 (6)
    d)  Other – please explain_____________________________________________________________________
Results: Six-minute walk test (6MWT) (n = 1), CPET (n = 2) 
_________________________________________________________________________________________________
In the absence of any other results:
  9. What instructions for daily activities would you give?
    a)  None  0
    b)  Recommend only mild exertion  3 (6)
    c)  Recommend moderate exertion  13 (25)
    d)  Instruct the patient to continue activity as tolerated  30 (57)
    e)  Other – please explain________________________  6 (11)
Results: Assess exercise capacity/6MWT (n = 3), review by physio/continue pulmonary rehab (n = 2), oxygen therapy 
(n = 2), symptom limited exercise (n = 3) 
_________________________________________________________________________________________________
For this question, more than one answer may be selected
10.    How would you guide the patient with respect to their daily activities? Would you:
    a)  Give verbal guidelines  38 (72)
    b)  Give written guidelines  20 (38)
    c)  Refer the patient for instruction  9 (17)
    d)  Refer the patient for exercise rehabilitation  33 (62)
    e)  Other – please explain_____________________________________________________________________
For this patient, which of the following symptoms would you consider to be acceptable during daily activities?
11.    Breathlessness 
    a)  Minimal  12 (23)
    b)  Moderate  23 (44)
    c) As much as the patient can tolerate  16 (30)
    d)  Other – please explain_____________________________________________________________________Journal of Multidisciplinary Healthcare 2011:4 submit your manuscript | www.dovepress.com
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12.    Light-headedness
    a)  None  30 (57)
    b)  Mild  20 (37)
    c)  Moderate  2 (4)
    d) To the point of syncope  0
    e)  Other – please explain_____________________________________________________________________
13.    Fatigue
    a)  None  3 (6)
    b)  Minimal  18 (33)
    c)  Moderate  20 (37)
    d) As much as the patient can tolerate  12 (22)
    e)  Other – please explain_____________________________________________________________________
14.    Chest pain
    a)  None  41 (78)
    b)  Mild  8 (16)
    c)  Moderate  1 (2)
    d) As much as the patient can tolerate  2 (4)
    e)  Other – please explain_____________________________________________________________________
Case 2
36-year-old female
WHO functional Class III
Six-minute walk distance 305 m on room air
ABGs on room air PaO2 88 mmHg (11.7 kPa), PaCO2 38 mmHg (5.1 kPa)
PAP 62/28, mean PAP 38 mmHg on resting RHC study
PVRI 671 dyne/s/m2/cm5
Moderately dilated right ventricle with moderate global impairment of RV systolic function
No evidence of thromboembolic disease
All usual tertiary hospital based assessment related to diagnosis and medical management has been performed.
In relation to exercise and activity prescription:  Results
15.   What further investigations would you perform?  n (%)
    a)  None  27 (51)
    b)  Exercise right heart catheter  8 (15)
    c)  Exercise echo  8 (15)
    d)  Other – please explain_____________________________________________________________________
Results: Lung function tests (n = 1), CT pulmonary angiogram (n = 1), 6MWT (n = 1), overnight oximetry (n = 1) 
_________________________________________________________________________________________________
In the absence of these results:
16.   What instructions for daily activities would you give?
    a)  None  0
    b)  Recommend only mild exertion  7 (13)
    c)  Recommend moderate exertion  5 (9)
    d)  Instruct the patient to continue activity as tolerated  30 (57)
    e)  Other – please explain_______________________  7 (13)
Results: Assess exercise capacity (n = 1)/6MWT (n = 2)/exercise right heart catheter (n = 1), cardiac or pulmonary rehab 
(n = 2), oxygen therapy (n = 1), symptom limited exercise (n = 3)/no strenuous exercise/Borg ,6
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For this question, more than one answer may be selected
17.    How would you guide the patient with respect to their daily activities? Would you:
    a)  Give verbal guidelines  33 (62)
    b)  Give written guidelines  13 (25)
    c)  Refer the patient for instruction  14 (26)
    d)  Refer the patient for exercise rehabilitation  32 (60)
    e)  Other – please explain_____________________________________________________________________
For this patient, which of the following symptoms would you consider to be acceptable during daily activities?
18.    Breathlessness 
    a)  Minimal  14 (26)
    b)  Moderate  20 (38)
    c) As much as the patient can tolerate  15 (28)
    d)  Other – please explain_____________________________________________________________________
19.    Light-headedness
    a)  None  27 (51)
    b)  Mild  20 (38)
    c)  Moderate  2 (4)
    d) To the point of syncope  0
    e)  Other – please explain_____________________________________________________________________
20.    Fatigue
    a)  None  4 (8)
    b)  Minimal  13 (25)
    c)  Moderate  18 (34)
    d) As much as the patient can tolerate  13 (25)
    e)  Other – please explain_____________________________________________________________________
21.    Chest pain
    a)  None  39 (74)
    b)  Mild  7 (13)
    c)  Moderate  2 (4)
    d) As much as the patient can tolerate  1 (2)
    e)  Other – please explain_____________________________________________________________________
Please circle either the yes or no response to each of the questions below:
22.    For a patient with established PAH in WHO functional class II would you advise:
  Results (n, %) (n, %)
    a)  Lifting 20 kg in weight  Yes (19, 36)  No (30, 57)
    b)  Exercising in a non-hospital gym  Yes (37, 70)  No (12, 23)
    c)  Regularly using stairs and slopes  Yes (42, 79)  No (7, 13)
    d) A sedentary lifestyle  Yes (1, 2)    No (48, 91)
23.    For a patient with established PAH in WHO functional class III would you advise:
    a)  Lifting 20 kg in weight  Yes (5, 9)    No (44, 83)
    b)  Exercising in a non-hospital gym  Yes (11, 21)  No (38, 72)
    c)  Regularly using stairs and slopes  Yes (27, 51)  No (22, 42)
    d) A sedentary lifestyle  Yes (4, 8)    No (45, 85)
24.    For a patient with established PAH in WHO functional class IV would you advise:
    a)  Lifting 20 kg in weight  Yes (0)      No (49, 92)
    b)  Exercising in a non-hospital gym  Yes (3, 6)    No (46, 87)Journal of Multidisciplinary Healthcare
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    c)  Regularly using stairs and slopes  Yes (6, 11)  No (43, 81)
    d) A sedentary lifestyle  Yes (9, 17)  No (40, 75)
Further comments about exercise/activity instructions, or the questionnaire:
Results: 
1)    Important all patients given an exercise prescription based on professional, experienced assessment (eg, physio); avoid 
heavy lifting and anaerobic activity; avoid breath holding (eg, during swimming)
2)   Exercise to tolerance after supervised exercise in hospital gym for all class II/III patients
3)   As good as a drug. Should be used in all cases
4)    Most patients in WHO II and III could do a rehab program but it would be PH related and most would benefit from 
one-on-one supervised training with a specialist
5)      For majority of patients exercise is advisable in consultation with treating physician and physiotherapist/pulmonary 
rehab co-ordinator in a monitored environment. Activity is always recommended however should be adjusted to patients’ 
  condition. Isometric exercises, gentle walking, and use of oxygen should be discussed individually with patients and 
carers.
Thank you again for your participation.
A/Prof Sue Jenkins is a lecturer and Robin Fowler is a PhD student at Curtin University.
If you wish to be informed of the collective results of this survey, please contact Robin Fowler via email at the 
 following address:
Robin.Fowler@health.wa.gov.au
Postal address:
c/ Advanced Lung Disease Unit
Royal Perth Hospital
Ainslie House, Murray Street
Box X2213 GPO
Perth 6847
Western Australia